-
Mashup Score: 0Experts debate reducing ASCT for multiple myeloma - 1 year(s) ago
Overall survival following multidrug regimens and transplant are on par, raising questions about the best frontline therapy for multiple myeloma.
Source: www.mdedge.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Sarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, discuss their research on wearable technology.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Sarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, discuss their research on wearable technology.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation - 1 year(s) ago
Key Points. Patients with mantle cell lymphoma have higher relative risks of respiratory, blood, and infectious disease compared with healthy comparators.Late e
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
This interim analysis provides support for considering carfilzomib, lenalidomide, and dexamethasone therapy in patients with newly diagnosed multiple myeloma who completed any induction regimen followed by autologous stem-cell transplantation, which requires confirmation after longer follow-up of this ongoing phase 3 trial.
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Gayathri Ravi, MD, discusses the role of minimal residual disease testing in patients with newly diagnosed multiple myeloma.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Age-adapted induction followed by high-dose chemoimmunotherapy and autologous transplant has shown promise for treating elderly, fit patients with primary central nervous system lymphoma.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Commonly Prescribed Restrictive Diet May Be Unnecessary Before Autologous Stem Cell Transplantation - The ASCO Post - 1 year(s) ago
By The ASCO Post Staff Posted: 12/11/2022 10:00:00 AM Last Updated: 12/11/2022 12:46:22 PM People undergoing a stem cell transplant for cancer do not derive any benefit from a restrictive diet that is commonly prescribed to prevent infections, according to a new trial presented by Stella et al at the 2022…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
To evaluate 1) the prognostic implication of baseline global longitudinal strain (GLS) and 2) the added value of GLS beyond the circulating cardiac biomarkers for risk stratification in patients with light chain (AL) amyloid undergoing autologous hematopoietic …
Source: PubMed Central (PMC)Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0The Stem Cell Transplant Daily - 2 year(s) ago
A selection of articles, blog posts, videos and photos recommended by Muzaffar Qazilbash
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet
Experts debate reducing #ASCT for #MultipleMyeloma 👉https://t.co/eKcFZSzpWD @MDedgeHemOnc https://t.co/Ph0zDwqaCg